Product Information
FELBAMATE 400 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.7978 per EA under NDC 72578005601. Its NADAC has been published 279 times since Jun 2, 2021.
FDA first approved this application on May 30, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578005601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FELBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA208970FDA Approved
5/30/2017
TE Code
AB
On Market Since
3/3/2020
Pharmacological Classes
Price Statistics
The NADAC for FELBAMATE 400 MG TABLET has been published 279 times since Jun 2, 2021, and over the history we have for it it has declined 61.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7978 per EA |
|---|---|
| All-time high | $2.4593 (Aug 11, 2021) |
| All-time low | $0.6785 (Jul 22, 2026) |
| 52-week high | $1.0316 |
| 52-week low | $0.6785 |
| Median price | $1.0013 |
| Average price | $1.1251 |
| Largest weekly change | +55.2% (Aug 17, 2022) |
| Weeks tracked | 279 |
| Tracking since | Jun 2, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viona Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Felbamate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FELBAMATE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.7978 per EA (NDC 72578005601), effective Sep 30, 2026.
How has the price of FELBAMATE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 61.2%. It has been tracked across 279 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?
Since Jun 2, 2021, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.6785 (Jul 22, 2026) to a high of $2.4593 (Aug 11, 2021), with a median of $1.0013 per EA.
Are there cheaper alternatives to FELBAMATE 400 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FELBAMATE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FELBAMATE 400 MG TABLET?
FELBAMATE 400 MG TABLET (NDC 72578005601) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.